Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1

Status

Completed 309Unknown 119Terminated 85Recruiting 39Active not recruiting 32Withdrawn 17Not yet recruiting 17Suspended 3Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Colonic Neoplasms 1

Interventions

Specimen Handling 8Magnetic Resonance Spectroscopy 7Biopsy 5Nivolumab 4Capecitabine 4Vincristine 3Radiosurgery 3Paclitaxel 3Irinotecan 3Fluorouracil 3Everolimus 3Docetaxel 3Dexamethasone 3Cyclophosphamide 3Cisplatin 3Bevacizumab 3trifluridine tipiracil drug combination 2spartalizumab 2pembrolizumab 2lenvatinib 2daratumumab 2Taxes 2Radiation 2Prednisone 2Pemetrexed 2Oxaliplatin 2Mitoxantrone 2Leucovorin 2Injections 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Suspended × Irinotecan × Clear all
NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended
477 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05358704 2025-12-04

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

Rutgers, The State University of New Jersey

Phase 2 Suspended
38 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00209664 2006-02-02

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 2 Suspended
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡